Dr. Tengiz Tkebuchava, MD, PhD

Founder & Director

Regenerative Medicine, Stem Cells, Exosomes, Cardiovascular Research

Dr. Tengiz Tkebuchava’s medical career did not develop in one country or within one narrow field. It moved over time through cardiac surgery, experimental research, medical technology, and later regenerative medicine. The line connecting these stages is visible, but not always obvious at first glance.

He studied medicine at Tbilisi State Medical University, where he graduated Summa Cum Laude. His early direction was cardiovascular medicine. Not as an abstract academic interest, but as work shaped by surgery, difficult pathology, and the limits of available treatment.

He later continued at the Bakulev Center for Cardiovascular Surgery in Moscow, where he completed his PhD. This was a period defined by intensive clinical exposure and research activity at the same time. Congenital and acquired cardiac disease, technically demanding procedures, and the daily reality of patients whose outcomes could change quickly. In that kind of setting, clinical judgment is formed under pressure. So is scientific discipline.

In 1989, he moved to Switzerland and continued his work in cardiac surgery centers in Zurich. Later, professional activity also took him to London. These moves mattered, but not because they simply added prestigious institutions to a résumé. Working in different systems changes how physicians think. The structure of hospitals changes. The habits of surgical teams change. What does not change is the need to make careful decisions in complex cases.

In 1997, Dr. Tkebuchava moved to the United States. His later work there expanded beyond surgery alone. Research became more central. So did biomedical innovation. Over time, his professional work was recognized internationally, and he received U.S. citizenship under the designation “Alien of Extraordinary Ability.”

That title is unusual. What matters more is the kind of work behind it.

Scientific Work of Dr. Tengiz Tkebuchava

Research has accompanied Dr. Tengiz Tkebuchava’s clinical activity for many years. It was not a separate academic layer added later. It developed alongside medical practice.

His work has included studies on congenital and acquired cardiac pathology, surgical treatment strategies, and later the development of biomedical technologies. Over the years, he became involved not only in patient care and research, but also in the design of new medical solutions and therapeutic concepts. This included patented technologies and broader work in biomedical innovation.

He later worked as a professor at Tufts University in Boston. Academic medicine was part of his professional life, but not in isolation from practice. Lectures, presentations, conferences, research discussions — these formed part of the same overall line of work. He also gave presentations at institutions including Harvard University.

Some physicians remain within one clinical framework for their entire careers. Others begin asking different questions. Not only how to treat disease, but how treatment itself might change. How technology changes options. How biological repair might alter what medicine can do.

That shift became increasingly visible in Dr. Tkebuchava’s later work.

Biomedical Innovation and Regenerative Medicine

Over time, Dr. Tengiz Tkebuchava’s interests moved more clearly into biomedical development and regenerative medicine.

He founded Boston Transtec, a U.S.-based medical technology company. This was not a break from his earlier work. It followed the same logic. Clinical frustration often leads serious physicians toward innovation. When conventional options remain limited, research and technology become more than side interests.

Regenerative medicine became one of the central areas of this later phase.

The basic question is simple, even if the science is not:
can damaged tissue be supported in repair rather than only removed, bypassed, or replaced?

In cardiovascular medicine, that question carries obvious weight. Heart tissue has limited regenerative capacity. Once damaged, recovery is often incomplete. That is why regenerative approaches have drawn attention for years, especially among researchers with a background in surgery and tissue injury.

Dr. Tkebuchava’s work in this field included research on regenerative bioagents, their therapeutic use, and possible delivery methods to cardiac tissue. The work was experimental and technical. It involved combinations of therapies, questions of application, and the broader problem that always exists in regenerative medicine: what is scientifically plausible, what is clinically meaningful, and what remains premature.

This area of expertise also led to advisory work with major medical companies, including Medtronic, Johnson & Johnson, Boston Scientific, and General Electric.

These roles matter, but not as decoration. They show where his work was being taken seriously.

Founding of RegMed Georgia

In 2021, Dr. Tengiz Tkebuchava founded the American Center of Regenerative Medicine in Georgia, known as RegMed Georgia.

The purpose was clear. Georgia did not have a long-established center focused specifically on regenerative medicine with the same international orientation he had known from years abroad. RegMed Georgia was created to bring that kind of work into a structured clinical setting, including the medical evaluation of advanced regenerative approaches such as stem cell therapies and exosome-based applications where appropriate.

He continues to serve as Founder and Director.

The significance of this is not in the title alone. Founding a center is one thing. Building a working medical structure around a demanding and still developing field is another. Regenerative medicine attracts attention easily. That is not the same as building something clinically serious.

Humanitarian Work

Another part of Dr. Tkebuchava’s background is connected to humanitarian work during the 1990s, when Georgia went through a severe economic and political crisis.

Many families faced shortages that affected daily life directly: food, medicine, basic supplies, access to care. During that period, he organized charitable assistance aimed at helping affected communities. The support included medical aid as well as essential humanitarian relief.

This work was later recognized in the United States Congress and mentioned by Voice of America.

Working Perspective

Medicine changes. Some fields change slowly. Others move in waves of enthusiasm, doubt, experimentation, and correction. Regenerative medicine has passed through all of these phases.

For that reason, caution matters just as much as innovation.

Dr. Tengiz Tkebuchava’s career has moved through surgery, research, technology, and regenerative medicine without treating them as separate identities. They are parts of the same professional logic. Clinical reality first. Scientific possibility second. And between the two, careful judgment.

Today he continues to divide his professional time between Georgia and the United States, while remaining active in research, international collaboration, and the ongoing development of regenerative medicine through RegMed Georgia.